CoChat
Cited by 154

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes

Marchesini, G., Forlani, G., Cerrelli, F., Manini, R., Natale, S., Baraldi, L., Ermini, G., Savorani, G., Zocchi, D., Melchionda, N. · 2004 · Diabetic Medicine

Abstract

Aims Different criteria have been proposed by the World Health Organization (WHO) and by the Third Report of the National Cholesterol Education Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATPIII) for the diagnosis of the metabolic syndrome. Its identification is of particular importance for coronary risk assessment. Methods The prevalence of the metabolic syndrome was determined according to the two different proposals in 1569 consecutive subjects with Type 2 diabetes. Results By the WHO proposal, 81% of cases (95% confidence interval, 79–83) were labelled as metabolic syndrome. Microalbuminuria had the highest specificity (99%) and visceral obesity the highest sensitivity (93%). Seventy‐eight per cent of patients (95% CI, 76–80) fulfilled the ATPIII criteria for metabolic syndrome, low HDL‐cholesterol having the highest specificity (95%), elevated blood pressure having the highest sensitivity. According to both proposals, 1113 patients were positive; 183 were concordantly negative, indicative of a fairly good agreement (k statistics, 0.464). Subjects only positive for the WHO proposal were more frequently males, had a lower BMI and a higher arterial pressure. Only subjects identified by the ATPIII proposal had a significantly higher prevalence of previously detected coronary heart disease. Conclusions Minimum criteria for the metabolic syndrome are met in most patients with Type 2 diabetes. Correct identification of the syndrome is important for an integrated approach to reduce the high costs and the associated disabilities. The ATPIII proposal more clearly identifies the burden of coronary heart disease associated with the metabolic syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2004.01115.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 154

Metadata

Authors
Marchesini, G., Forlani, G., Cerrelli, F., Manini, R., Natale, S., Baraldi, L., Ermini, G., Savorani, G., Zocchi, D., & Melchionda, N.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2004-02-20
Volume
21
Issue
4
Pages
383-387
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2103484632
Cited by
154
References
9
FWCI
9.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. https://app.cochat.ai/papers/10.1111/j.1464-5491.2004.01115.x
The paper
Marchesini, G., Forlani, G., Cerrelli, F., Manini, R., Natale, S., Baraldi, L., Ermini, G., Savorani, G., Zocchi, D., & Melchionda, N. (2004). WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2004.01115.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.